ℹ️
🇬🇧
Search
Search for publications relevant for "ERBB2"
ERBB2
Publication
Class
Person
Publication
Programmes
Export current view
publication
Quantitative RT-PCR as a tool solving discerepant results between ERBB2 gene coopy numbers and expression of the ERBB-2 protein: An improvement of Herceptin therapy indication in breast carcinomas
2002 |
Central Library of Charles University, Second Faculty of Medicine
publication
Relative quantification of ERBB2 mRNA in invasive duct carcinoma of the breast: Correlation with ERBB-2 protein expression and ERBB2 gene copy number
2003 |
Second Faculty of Medicine
publication
Therapy Indication of Patients with Invasive Duct Carcinomas of the Breast for Herceptin from the Point of Laboratory Diagnostics- Investigation of ERBB-2 Protein Expression and Copy Numbers of the ERBB2 Gene. A Rewiev.
2002 |
Central Library of Charles University, Second Faculty of Medicine
publication
Molecular and Immunohistochemical Analysis of ERBB2 Expression in Correlation With Proliferation Rate in Synovial Sarcoma
2007 |
Second Faculty of Medicine
publication
A modified approach for I-FISH evaluation of ERBB2 (HER-2) gene copy numbers in breast carcinomas: comparison with HER-2/CEP17 ratio system
2007 |
Second Faculty of Medicine
publication
Paget's disease of the nipple: a copy number of the genes ERBB2 and CCND1 versus expression of the proteins ERBB-2 and cyclin D1
2003 |
Second Faculty of Medicine
publication
Erbb2 Is Required for Cardiac Atrial Electrical Activity during Development
2014 |
First Faculty of Medicine
publication
Patients with neuregulin 1 (NRG1) rearranged cancer are suitable for the theranostic approach and targeted therapy
2022 |
Faculty of Medicine in Pilsen, Second Faculty of Medicine
publication
Quantitative RT-PCR as a tool solving discerepant results between ERBB2 gene copy numbers and expression of the ERBB -2 protein: An improvement of Herceptin therapy indication in breast carcinomas
Publication without faculty affiliation
publication
Pilotní studie sledování exprese receptoru her2, amplifikace genu ERBB2 a mutace genu KRAS jako predikace biologické léčby trastuzumabem u pacientů s karcinomem žaludku
2010 |
Faculty of Medicine in Pilsen
publication
Somatic genomic and transcriptomic characterization of primary ovarian serous borderline tumors and low-grade serous carcinomas
2024 |
Second Faculty of Medicine, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
News in adjuvant therapy for breast cancer
2015 |
First Faculty of Medicine
publication
Metastatic HER2-positive breast cancer - a new standard of treatment
2015 |
First Faculty of Medicine
publication
Clinical and functional importance of selected CASP8 and CASP9 polymorphisms in breast carcinoma
2016 |
Central Library of Charles University, Second Faculty of Medicine, First Faculty of Medicine, Third Faculty of Medicine
publication
Využití pertuzumabu v léčbě metastatického karcinomu prsu
2021 |
First Faculty of Medicine
publication
How to survive in the vastness of molecules: a view from a pathologist
2004 |
Second Faculty of Medicine
publication
Starší pacientka léčená afatinibem
2016 |
First Faculty of Medicine
publication
Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications
2019 |
Faculty of Medicine in Pilsen
publication
ALK alterations in salivary gland carcinomas
2021 |
Faculty of Medicine in Hradec Králové
publication
HPV Status and Mutation Analysis Using Multiparallel Sequencing in Distal Oesophageal and Gastro-oesophageal Junction Adenocarcinomas
2018 |
Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis
2019 |
Faculty of Medicine in Pilsen
publication
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—results from an international, multicenter analysis coordinated by the AGMT Study Group
2023 |
Faculty of Medicine in Pilsen
publication
Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative
2017 |
First Faculty of Medicine
publication
Karcinom plic - svítání nad vodami?
2021 |
Faculty of Medicine in Pilsen